The safety and efficacy of SGLT2 inhibitors

SLGT2 Inhibitors

Since the SGLT-2 inhibitors have been launched there have been studies that have suggested potential concerns such as ketoacidosis and amputation and those that have demonstrated positive benefits on cardiovascular outcomes. This meta-analysis of the drugs may dispel the anxieties that some primary care clinicians have had over prescribing them.

http://jaha.ahajournals.org/content/7/2/e007165

Share

Related Articles

24th August 2011

Is Pioglitazone Safe?

At last, we have clear guidance from the European Medicines Agency on the use of pioglitazone in people with diabetes...

Read More

30th November 2018

Defusing the ticking time bomb – with soft drinks?

Diabetes has been in the headlines again this week, for very contrasting reasons. In this article in the Diabetes...

Read More

30th January 2014

Diabetes & Wellbeing – book review

Diabetes and Well-Being by Dr Jen Nash Publisher Wiley-Blackwell There must be hundreds of books published every year...

Read More